Expression patterns and prognostic significance of inhibitor of apoptosis proteins in adenoid cystic carcinoma and pleomorphic adenoma of lachrymal gland

Experimental Eye Research

Volumn 88, Issue 1, 2009, Pages 4-11

  Liao, Yongchuan ^a   Zeng, Hao ^a   Wang, Xiaojie ^b   Huang, Ying ^a   Chen, Ni ^a   Ge, Bo ^a   Tang, Li ^a   Luo, Qinli ^a  

^a SICHUAN UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

adenoid cystic carcinoma; inhibitor of apoptosis protein; lachrymal gland; prognosis; survivin

Indexed keywords

INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; KI 67 ANTIGEN; LIVIN; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ADENOID CYSTIC CARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LACRIMAL GLAND TUMOR; MALE; NUCLEOTIDE SEQUENCE; PLEOMORPHIC ADENOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL RATE;

ADENOMA, PLEOMORPHIC; ADOLESCENT; ADULT; AGED; CARCINOMA, ADENOID CYSTIC; GENE EXPRESSION; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LACRIMAL APPARATUS DISEASES; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PARAFFIN EMBEDDING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 57549119111     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2008.09.015     Document Type: Article

References (36)

1. Akyurek N., Ren Y., Rassidakis G.Z., Schlette E.J., and Medeiros L.J. Expression of inhibitor of apoptosis proteins in B-cell non-Hodgkin and Hodgkin lymphomas. Cancer 107 (2006) 1844-1851
2. Altieri D.C. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22 (2003) 8581-8589
3. Borst P., Borst J., and Smets L.A. Does resistance to apoptosis affect clinical response to antitumor drugs?. Drug. Res. Up. 4 (2001) 129-131
4. Chen N., and Zhou Q. Constructing tissue microarrays without prefabricating recipient blocks: a novel approach. Am. J. Clin. Pathol. 124 (2005) 103-107
5. Chen W.C., Liu Q., Fu J.X., and Kang S.Y. Expression of survivin and its significance in colorectal cancer. World J. Gastroenterol. 10 (2004) 2886-2889
6. Deveraux Q.L., and Reed J.C. IAP family proteins: suppressors of apoptosis. Genes Dev. 13 (1999) 239-252
7. Ekedahl J., Joseph B., Grigoriev M.Y., Müller M., Magnusson C., Lewensohn R., and Zhivotovsky B. Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells. Exp. Cell. Res. 279 (2002) 277-290
8. Esmaeli B., Ahmadi M.A., Youssef A., Diba R., Amato M., Myers J.N., Kies M., and El-Naggar A. Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland. Ophthal. Plast. Reconstr. Surg. 20 (2004) 22-26
9. Espinosa M., Cantú D., Herrera N., Lopez C.M., De la Garza J.G., Maldonado V., and Melendez-Zajgla J. Inhibitors of apoptosis proteins in human cervical cancer. BMC Cancer 6 (2006) 45-55
10. Fukuda S., and Pelus L.M. Survivin a cancer target with an emerging role in normal adult tissues. Mol. Cancer Ther. 5 (2006) 1087-1098
11. Gordon G.J., Mani M., Mukhopadhyay L., Dong L., Edenfield H.R., Glickman J.N., Yeap B.Y., Sugarbaker D.J., and Bueno R. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma. J. Pathol. 211 (2007) 447-454
12. Greene, F.L., Page, D.L., Fleming, I.D., Fritz, A., Charles, M., 2002. AJCC Cancer Staging Handbook. sixth ed. Philadelphia, PA, pp. 276-277.
13. Johnson M.E., and Howerth E.W. Survivin: a bifunctional inhibitor of apoptosis protein. Vet. Pathol. 41 (2004) 599-607
14. Kami K., Doi R., Koizumi M., Toyoda E., Mori T., Ito D., Fujimoto K., Wada M., Miyatake S., and Imamura M. Survivin expression is a prognostic marker in pancreatic cancer patients. Surgery 136 (2004) 443-448
15. Kempkensteffen C., Hinz S., Christoph F., Kollermann J., Krause H., Schrader M., Schostak M., Miller K., and Weikert S. Expression parameters of the inhibitors of apoptosis cIAP1 and cIAP2 in renal cell carcinomas and their prognostic relevance. Int. J. Cancer 120 (2007) 1081-1086
16. Kennedy S.M., O'Driscoll L., Purcell R., Fitz-Simons N., McDermott E.W., Hill A.D., O'Higgins N.J., Parkinson M., Linehan R., and Clynes M. Prognostic importance of survivin in breast cancer. Br. J. Cancer 88 (2003) 1077-1083
17. Krajewska M., Krajewski S., Banares S., Huang X., Turner B., Bubendorf L., Kallioniemi O.P., Shabaik A., Vitiello A., Peehl D., Gao G.J., and Reed J.C. Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin. Cancer Res. 9 (2003) 4914-4925
18. Lee D.A., Campbell R.J., Waller R.R., and Ilstrup D.M. A clinicopathologic study of primary adenoid cystic carcinoma of the lacrimal gland. Ophthalmology 92 (1985) 128-134
19. Li F., and Ling X. Survivin study: an update of "What is the next wave?" J. Cell. Physiol. 208 (2006) 476-486
20. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., and Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396 (1998) 580-584
21. Li F., Yang J., Ramnath N., Javle M.M., and Tan D.F. Nuclear or cytoplasmic expression of survivin: what is the significance?. Int. J. Cancer 114 (2005) 509-512
22. Miller R.T., and Kubier P. Blocking of endogenous avidin binding activity in immunohistochemistry: the use of skim milk as an economical and effective substitute for commercial biotin solutions. Appl. Immunohistochem. Mol. Morphol. 7 (1999) 63-65
23. Mizutani Y., Nakanishi H., Li Y.N., Matsubara H., Yamamoto K., Sato N., Shiraishi T., Nakamura T., Mikami K., Okihara K., Takaha N., Ukimura O., Kawauchi A., Nonomura N., Bonavida B., and Miki T. Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis. Int. J. Oncol. 30 (2007) 919-925
24. Nemoto T., Kitagawa M., Hasegawa M., Ikeda S., Akashi T., Takizawa T., Hirokawa K., and Koike M. Expression of IAP family proteins in esophageal cancer. Exp. Mol. Pathol. 76 (2004) 253-259
25. O'Driscoll L., Linehan R., Kennedy S.M., Cronin D., Purcell R., Glynn S., McDermott E.W., Hill A.D., O'Higgins N.J., Parkinson M., and Clynes M. Lack of prognostic significance of survivin, survivin-yEx3, survivin-2B, galectin-3, bag-1, bax-a and MRP-1 mRNAs in breast cancer. Cancer Lett. 201 (2003) 225-236
26. Okada E., Murai Y., Matsui K., Isizawa S., Cheng C., Masuda M., and Takano Y. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett. 163 (2001) 109-116
27. Reed J.C. Apoptosis-regulating proteins as targets for drug discovery. Trends Mol. Med. 7 (2001) 314-319
28. Sarela A.I., Scott N., Ramsdale J., Markham A.F., and Guillou P.J. Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann. Surg. Oncol. 8 (2001) 305-310
29. Schmitt C.A., and Lowe S.W. Apoptosis is critical for drug response in vivo. Drug. Res. Up. 4 (2001) 132-134
30. Span P.N., Sweep F.C., Wiegerinck E.T., Tjan-Heijnen V.C., Manders P., Beex L.V., and de Kok J.B. Survivin is an independent prognostic marker for risk stratification of breast cancer patients. Clin. Chem. 50 (2004) 1986-1993
31. Spencer W.H. Ophthalmic Pathology: an Atlas and Textbooks (1996), WB Saunders Co., Philadelphia, PA pp. 2494-2509
32. Tanaka K., Iwamoto S., Gon G., Nohara T., Iwamoto M., and Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin. Cancer. Res. 6 (2000) 127-134
33. Trieb K., Lehner R., Stulnig T., Sulzbacher I., and Shroyer K.R. Survivin expression in human osteosarcoma is a marker for survival. Eur. J. Surg. Oncol. 29 (2003) 379-382
34. Vischioni B., van der Valk P., Ing S.W.S., Kruyt F.A.E., Rodriguez J.A., and Giaccone G. Expression and localization of inhibitor of apoptosis proteins in normal human tissues. Hum. Pathol. 37 (2006) 78-86
35. Yang Y., Fang S., Jensen J.P., Weissman A.M., and Ashwell J.D. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science (Wash. DC) 288 (2000) 874-877
36. Zaffaroni N., Pennati M., and Daidone M.G. Survivin as a target for new anticancer interventions. J. Cell. Mol. Med. 9 (2005) 360-372